Many exciting developments are occurring in breast imaging. Some, such as d
igital mammography, have the potential to change the field radically, while
others will have effects that are more subtle but are equally important. D
igital mammography holds the promise of telemammography and computer-aided
diagnosis. Mammoscintigraphy may be helpful in identifying drug-resistant t
umors before therapy. There is renewed interest in evaluating ultrasound as
a potential adjunctive screening tool in women with radiographically dense
breasts. Finally, contrast-enhanced magnetic resonance (MR) imaging may be
used more extensively in monitoring tumor response to primary chemotherapy
and in the preoperative assessment of patients being considered for breast
conservation therapy.